Probable etoposide interaction with echinacea

Journal of Dietary Supplements

Volumn 9, Issue 2, 2012, Pages 90-95

  Bossaer, John B ^a   Odle, Brian L ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Drug interactions; Echinacea; etoposide; Herbal supplements; Thrombocytopenia

Indexed keywords

ANTINEOPLASTIC AGENT; CYP3A4 PROTEIN, MOUSE; CYTOCHROME P450 3A; ETOPOSIDE; PLANT EXTRACT;

ARTICLE; BLOOD; CASE REPORT; DIET SUPPLEMENTATION; DRUG ANTAGONISM; ECHINACEA; HERB DRUG INTERACTION; HUMAN; LUNG NON SMALL CELL CANCER; MALE; METABOLISM; MIDDLE AGED; PHYTOTHERAPY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD PLATELETS; CARCINOMA, NON-SMALL-CELL LUNG; CYTOCHROME P-450 CYP3A; DIETARY SUPPLEMENTS; ECHINACEA; ETOPOSIDE; HERB-DRUG INTERACTIONS; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PLATELET COUNT; THROMBOCYTOPENIA;

EID: 84861326681     PISSN: 19390211     EISSN: 1939022X     Source Type: Journal    
DOI: 10.3109/19390211.2012.682643     Document Type: Article

References (15)

1. Albain KS,Crowley JJ, TurrisiAT III, Gandara DR, FarrarWB, Clark JI, Beasley KR, Livingston RB. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB nonsmall-cell lung cancer: A Southwestern Oncology Group Phase II Study, SWOG 9019. J Clin Onc. 2002;20:3454-3460.
2. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT 3rd, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR, Fosmire H, Taylor SA, Stelzer KJ, Beasley KR, Livingston RB. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwestern Oncology Group Phase II Study S 8805. J Clin Onc. 1995;13:1880-1892.
3. Armstrong E Frankland. Glucosides. In WA Davis and SS Sadtler (Eds.), Allen's commercial organic analysis (2nd ed.), p. 102. Philadelphia: P. Blakiston's Son & Co, 1913.
4. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008 Dec 10(12):1-23.
5. Borchers AT, Keen CL, Stern JS, Gershwin ME. Inflammation and Native American medicine: The role of botanicals. Am J Clin Nutr. 2000;72(2):339-347. Review. (Pubitemid 30620636)
6. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000;7:273-82. (Pubitemid 30618491)
7. Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, v3.0 (CTCAE). Bethesda, MD: National Cancer Institute, 2006. Retrieved May 18, 2011, from http://ctep.cancer.gov/protocoldevelopment/ electronic applications/docs/ctcaev3.pdf
8. Ellison NM, Byar DP, Newell GR. Special report on laetrile: The NCI Laetrile Review. Results of the National Cancer Institute's retrospective laetrile analysis. N Engl J Med. 1978;299(10):549-552. (Pubitemid 9053826)
9. Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD. The effect of Echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther. 2004;75:89-100. (Pubitemid 38130121)
10. Laetrile (apricot kernel) FullMonograph. Natural Medicines ComprehensiveDatabaseWeb site. Retrieved May 18, 2011, from http:// naturaldatabase.therapeuticresearch.com. Stockton, CA: Therapeutic Research Faculty, April 2011.
11. Moertel CG, Fleming TR, Rubin J, Kvols LK, Sarna G, Koch R, Currie VE, Young CW, Jones SE, Davignon JP. A clinical trial of amygdalin (laetrile) in the treatment of human cancer. N Engl J Med. 1982;306:201-206. (Pubitemid 12163108)
12. Relling MV, Evans R, Dass C, Desiderio DM, Nemec J. Human cytochrome P450 metabolism of teniposide and etoposide. J Pharmacol Exp Ther. 1992;261:491-496.
13. Rodman JH, Murry DJ, Madden T, Santana VM. Pharmacokinetics of high dose etoposide and the influence of anticonvulsants in pediatric cancer patients. Clin Pharmacol Ther. 1992;51:156. Teva. Toposar (etoposide) package insert. Irvine, CA, 2007.
14. vanMaanen JM, LafleurMV, Mans DR, van den Akker E, de Ruiter C, Kootstra PR, Pappie D, de Vries J, Retèl J, Pinedo HM. Effects of the ortho-quinone and catechol of the antitumor drug VP-16-213 on the biological activity of single-stranded and double-stranded phi X174 DNA. Biochem Pharmacol. 1988;37:3579-3589.
15. Yong WP, Desai AA, Innocenti F, Ramirez J, Shepard D, Kobayashi K, House L, Fleming GF, Vogelzang NJ, Schilsky RL, RatainMJ. Pharmocokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer. Cancer Chemother Pharmacol. 2007;60:811-819. (Pubitemid 47389387)